These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 170689)

  • 21. Epstein-Barr virus and human malignancy.
    Ziegler JL; Magrath IT; Gerber P; Levine PH
    Ann Intern Med; 1977 Mar; 86(3):323-36. PubMed ID: 190930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
    Klein G
    Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody patterns in different human sera against intracellular and membrane-antigen complexes associated with Epstein-Barr virus.
    Svedmyr A; Demissie A; Klein G; Clifford P
    J Natl Cancer Inst; 1970 Mar; 44(3):595-610. PubMed ID: 11515428
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell-mediated immune responses in man to Epstein-Barr (EB) virus infection.
    Lai PK; Alpers MP
    Comp Immunol Microbiol Infect Dis; 1979; 2(4):565-85. PubMed ID: 232867
    [No Abstract]   [Full Text] [Related]  

  • 25. Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression.
    Purtilo DT; Sakamoto K
    Hum Pathol; 1981 Aug; 12(8):677-9. PubMed ID: 6269987
    [No Abstract]   [Full Text] [Related]  

  • 26. Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion.
    Demissie A
    J Natl Cancer Inst; 1973 Sep; 51(3):751-60. PubMed ID: 4355217
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
    Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
    J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes viruses and oncogenesis.
    Klein G
    Johns Hopkins Med J Suppl; 1974; 3():15-25. PubMed ID: 4370988
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
    Bachmann AE; Giraudo Conesa LC; Braun M
    Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
    [No Abstract]   [Full Text] [Related]  

  • 30. IgA and nasopharyngeal carcinoma.
    Desgranges C; De-The G
    IARC Sci Publ (1971); 1978; (24 Pt 2):883-91. PubMed ID: 221410
    [No Abstract]   [Full Text] [Related]  

  • 31. [Epstein-Barr virus. Its participation in lymphoproliferative and anaplastic processes].
    Fejes M; Bachmann AE; Mochanko K
    Medicina (B Aires); 1978; 38(6 Pt 1):700-16. PubMed ID: 220495
    [No Abstract]   [Full Text] [Related]  

  • 32. Host responses to herpesviruses - a review.
    Henle W; Henle G
    IARC Sci Publ (1971); 1975; (11 Pt 2):215-24. PubMed ID: 191365
    [No Abstract]   [Full Text] [Related]  

  • 33. [The diagnostic value of Epstein-Barr virus diagnosis].
    Bauer G
    Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107
    [No Abstract]   [Full Text] [Related]  

  • 34. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Burkitt's lymphoma].
    Gombos F; Serpico R; Femiano F
    Arch Stomatol (Napoli); 1984; 25(4):329-38. PubMed ID: 6100729
    [No Abstract]   [Full Text] [Related]  

  • 37. The oncogenicity of Epstein-Barr virus.
    Miller G
    J Infect Dis; 1974 Aug; 130(2):187-205. PubMed ID: 4366977
    [No Abstract]   [Full Text] [Related]  

  • 38. Epstein-Barr virus serologic testing: diagnostic indications and interpretations.
    Sumaya CV
    Pediatr Infect Dis; 1986; 5(3):337-42. PubMed ID: 3014456
    [No Abstract]   [Full Text] [Related]  

  • 39. Various forms of Epstein-Barr virus infection in man: established facts and a general concept.
    Epstein MA; Achong BG
    Lancet; 1973 Oct; 2(7833):836-9. PubMed ID: 4126630
    [No Abstract]   [Full Text] [Related]  

  • 40. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
    Hewetson JF; Rocchi G; Henle W; Henle G
    J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.